Health Condition 1: G060- Intracranial abscess and granuloma
Conditions
Interventions
Intervention1: Evaluation of lignocaine infusion for management of pain after supratentorial craniotomy: Group A patients undergoing supratentorial craniotomy will be given intravenous Lignocaine bolu
Sponsors
Dayanand Medical College and Hospital
Eligibility
Inclusion criteria
Inclusion criteria: Adult male and femalae patients undergoing supratentorial craniotomy under General Anesthesia, American Society of Anaesthesiologist(ASA) Class 1 and 2, Glasgow Coma Scale of 15.
Exclusion criteria
Exclusion criteria: 1. Patients having cardiac conduction abnormalities like atrio-ventricular block. 2. Patients with respiratory, hepatic or renal disease. 3. Patients on treatment with calcium channel blockers or beta-blockers. 4. Patients with altered sensorium. 5. Patients with a history of myopathy or substance abuse. 6. Patients who will be kept mechanically ventilated postoperatively. 7. Allergic to study drug. 8. Patient’s refusal.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Analgesic efficacy of IV lignocaine infusion as assessed by post operative pain score measured using Numeric rating scale (NRS).Timepoint: Analgesic efficacy of IV lignocaine infusion as assessed by post operative pain score measured using Numeric rating scale (NRS)measured after shifting the patients to post anaesthesia care unit at 0 hour, 1 hour, 2 hour and 3 hour. | — |
Secondary
| Measure | Time frame |
|---|---|
| 1.Total opioid consumption in 24 hours from start of surgery 2.To observe for adverse effects, if any during surgery & within 24 hours of surgeryTimepoint: 1.Total opioid consumption till 24 hours after surgery 2.To observe for adverse effects within 24 hours of surgery | — |
Countries
India
Contacts
Public ContactDr Supreen kaur
Dayanand Medical College and Hospital
Outcome results
None listed